Stay updated on Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.

Latest updates to the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page
- Check4 days agoChange DetectedThe page’s revision tag changed from v3.6.0 to v3.6.2, indicating a newer revision of the page metadata. This appears to be a metadata update rather than a modification to the study content or visible data.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', signaling that enrollment has ended. New help and navigation sections—'How to Read a Study Record', 'Common Questions', 'How to Join a Study'—were added, and the Intervention/Treatment heading formatting was adjusted as the revision note shows v3.6.0 replacing v3.5.4.SummaryDifference0.6%

- Check47 days agoChange DetectedA new revision tag 'Revision: v3.5.4' has been added to the study record, and the previous revision 'Revision: v3.5.3' has been removed.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page’s revision label was updated from v3.5.2 to v3.5.3, indicating a minor site software/version update without changing the study details.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check104 days agoChange DetectedRevision updated to v3.5.0, replacing v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.